Chemours (CC) Set to Announce Quarterly Earnings on Thursday

Chemours (NYSE:CC) is scheduled to announce its earnings results after the market closes on Thursday, August 1st. Analysts expect the company to announce earnings of $0.69 per share for the quarter. Persons that are interested in registering for the company’s earnings conference call can do so using this link.

Chemours (NYSE:CC) last released its earnings results on Tuesday, April 30th. The specialty chemicals company reported $0.32 EPS for the quarter, topping the consensus estimate of $0.25 by $0.07. Chemours had a negative net margin of 5.51% and a positive return on equity of 46.67%. The firm had revenue of $1.35 billion during the quarter, compared to analysts’ expectations of $1.35 billion. During the same period in the previous year, the company earned $0.98 EPS. Chemours’s revenue for the quarter was down 12.1% on a year-over-year basis. On average, analysts expect Chemours to post $2 EPS for the current fiscal year and $3 EPS for the next fiscal year.

Chemours Trading Down 0.4 %

Shares of Chemours stock opened at $23.76 on Wednesday. The firm has a market cap of $3.54 billion, a PE ratio of -10.95 and a beta of 1.80. The company has a quick ratio of 0.99, a current ratio of 1.61 and a debt-to-equity ratio of 5.26. Chemours has a fifty-two week low of $15.10 and a fifty-two week high of $37.83. The business’s fifty day moving average is $24.06 and its two-hundred day moving average is $26.51.

Chemours Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, September 13th. Investors of record on Thursday, August 15th will be given a dividend of $0.25 per share. The ex-dividend date is Thursday, August 15th. This represents a $1.00 annualized dividend and a yield of 4.21%. Chemours’s dividend payout ratio (DPR) is presently -46.08%.

Analysts Set New Price Targets

A number of research firms have recently commented on CC. BMO Capital Markets raised shares of Chemours from an “underperform” rating to an “outperform” rating and upped their price objective for the company from $19.00 to $34.00 in a research note on Tuesday, April 9th. UBS Group raised shares of Chemours from a “neutral” rating to a “buy” rating and upped their price target for the stock from $28.00 to $30.00 in a research report on Tuesday, July 9th. Mizuho started coverage on shares of Chemours in a report on Friday, June 7th. They issued a “neutral” rating and a $25.00 price target on the stock. Finally, Barclays dropped their price objective on Chemours from $32.00 to $30.00 and set an “equal weight” rating for the company in a report on Tuesday, April 2nd. Six analysts have rated the stock with a hold rating and three have given a buy rating to the company. Based on data from MarketBeat.com, Chemours has an average rating of “Hold” and a consensus target price of $30.38.

About Chemours

The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through three segments: Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. The Titanium Technologies segment provides TiO2 pigment under the Ti-Pure brand for delivering whiteness, brightness, opacity, durability, efficiency, and protection in various of applications, such as architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride, laminate papers used for furniture and building materials, coated paper, and coated paperboard used for packaging.